{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:13:18Z","timestamp":1791216798632,"version":"4.1.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T00:00:00Z","timestamp":1705190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Research Grant Council","award":["27117022"],"award-info":[{"award-number":["27117022"]}]},{"name":"Research Grant Council","award":["14113923"],"award-info":[{"award-number":["14113923"]}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Food and Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Committee Postdoctoral Fellowship Scheme of the Chinese University of Hong Kong"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Despite recent advances in antidepressants in treating major depression (MDD), their usage is marred by adverse effects and social stigmas. Probiotics may be an efficacious adjunct or standalone treatment, potentially circumventing the aforementioned issues with antidepressants. However, there is a lack of head-to-head clinical trials between these 2 interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>A systematic review and network meta-analysis was conducted to compare the efficacy and acceptability of these 2 interventions in treating MDD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources<\/jats:title>\n                    <jats:p>Six databases and registry platforms for the clinical trial were systematically searched to identify the eligible double-blinded, randomized controlled trials published between 2015 and 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Exaction<\/jats:title>\n                    <jats:p>Two authors selected independently the placebo-controlled trials of antidepressants and microbiota-targeted interventions (prebiotics, probiotics, and synbiotics) used for the treatment of MDD in adults (\u226518\u2009years old). Standardized mean differences (SMDs) of depressive symptom scores from individual trials were pooled for network meta-analysis (PROSPERO no. CRD42020222305).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-two eligible trials covering 22 interventions were identified, of which 16 were found to be effective in MDD treatment and the certainty of evidence was moderate to very low. When all trials were considered, compared with placebo, SMDs of interventions ranged from \u22120.16 (95% credible interval: \u22120.30, \u22120.04) for venlafaxine to \u22120.81 (\u22121.06, \u22120.52) for escitalopram. Probiotics were superior to brexpiprazole (SMD [95% credible interval]: \u22120.42 [\u22120.68, \u22120.17]), cariprazine (\u22120.44 [\u22120.69, \u22120.24]), citalopram (\u22120.37 [\u22120.66, \u22120.07]), duloxetine (\u22120.26, [\u22120.51, \u22120.04]), desvenlafaxine (\u22120.38 [\u22120.63, \u22120.14]), ketamine (\u22120.32 [\u22120.66, \u22120.01]), venlafaxine (\u22120.47 [\u22120.73, \u22120.23]), vilazodone (\u22120.37 [\u22120.61, \u22120.12]), vortioxetine (\u22120.39 [\u22120.63, \u22120.15]), and placebo (\u22120.62 [\u22120.86, \u22120.42]), and were noninferior to other antidepressants. In addition, probiotics ranked the second highest in the treatment hierarchy after escitalopram. Long-term treatment (\u22658\u2009weeks) using probiotics showed the same tolerability as antidepressants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Probiotics, compared with antidepressants and placebo, may be efficacious as an adjunct or standalone therapy for treating MDD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>PROSPERO registration no. CRD42020222305.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/nutrit\/nuad171","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T20:08:23Z","timestamp":1703102903000},"page":"72-82","source":"Crossref","is-referenced-by-count":26,"title":["Probiotics for adults with major depressive disorder compared with antidepressants: a systematic review and network meta-analysis"],"prefix":"10.1093","volume":"83","author":[{"given":"Shilin","family":"Zhao","sequence":"first","affiliation":[{"name":"Microbiota I-Center (MagIC) , Hong Kong Special Administrative Region (SAR),","place":["China"]},{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]},{"name":"System Microbiology and Antimicrobial Resistance (SMART) Lab, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suisha","family":"Liang","sequence":"additional","affiliation":[{"name":"Microbiota I-Center (MagIC) , Hong Kong Special Administrative Region (SAR),","place":["China"]},{"name":"System Microbiology and Antimicrobial Resistance (SMART) Lab, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tao","sequence":"additional","affiliation":[{"name":"School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Peng","sequence":"additional","affiliation":[{"name":"Microbiota I-Center (MagIC) , Hong Kong Special Administrative Region (SAR),","place":["China"]},{"name":"System Microbiology and Antimicrobial Resistance (SMART) Lab, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]},{"name":"The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Maternal and Child Medicine Research Institute, Shenzhen Maternity and Child Healthcare Hospital , Shenzhen,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hogan K F","family":"Wai","sequence":"additional","affiliation":[{"name":"School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ying","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Taipei Municipal Wanfang Hospital , Taipei,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen Y","family":"Sin","sequence":"additional","affiliation":[{"name":"System Microbiology and Antimicrobial Resistance (SMART) Lab, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]},{"name":"The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K L","family":"Wong","sequence":"additional","affiliation":[{"name":"Microbiota I-Center (MagIC) , Hong Kong Special Administrative Region (SAR),","place":["China"]},{"name":"System Microbiology and Antimicrobial Resistance (SMART) Lab, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M","family":"Haqq","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta , Edmonton,","place":["Canada"]},{"name":"Department of Agricultural Food and Nutritional Science, University of Alberta , Edmonton,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y","family":"Ni","sequence":"additional","affiliation":[{"name":"School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis K L","family":"Chan","sequence":"additional","affiliation":[{"name":"Microbiota I-Center (MagIC) , Hong Kong Special Administrative Region (SAR),","place":["China"]},{"name":"Centre for Gut Microbiota Research, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew C","family":"Ng","sequence":"additional","affiliation":[{"name":"Microbiota I-Center (MagIC) , Hong Kong Special Administrative Region (SAR),","place":["China"]},{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]},{"name":"Li Ka Shing Institute of Health Sciences, State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7597-5062","authenticated-orcid":false,"given":"Hein M","family":"Tun","sequence":"additional","affiliation":[{"name":"Microbiota I-Center (MagIC) , Hong Kong Special Administrative Region (SAR),","place":["China"]},{"name":"System Microbiology and Antimicrobial Resistance (SMART) Lab, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]},{"name":"The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong , Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,14]]},"reference":[{"key":"2024121109571538000_nuad171-B1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(11)60602-8","article-title":"Major depressive disorder: new clinical, neurobiological, and treatment perspectives","volume":"379","author":"Kupfer","year":"2012","journal-title":"Lancet"},{"key":"2024121109571538000_nuad171-B2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/bmjebm-2019-111238","article-title":"Should antidepressants be used for major depressive disorder?","volume":"25","author":"Jakobsen","year":"2020","journal-title":"BMJ Evid Based Med"},{"key":"2024121109571538000_nuad171-B3","author":"Ferrari","year":"2014"},{"key":"2024121109571538000_nuad171-B4","article-title":"Antidepressant use among persons aged 12 and over: United States, 2011-2014","author":"Pratt","year":"2017","journal-title":"NCHS data brief, no 283"},{"key":"2024121109571538000_nuad171-B5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41398-019-0460-3","article-title":"Prognosis and improved outcomes in major depression: a review","volume":"9","author":"Kraus","year":"2019","journal-title":"Transl Psychiatry"},{"key":"2024121109571538000_nuad171-B6","author":"Debra","year":"2020"},{"key":"2024121109571538000_nuad171-B7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s43856-021-00046-8","article-title":"Understanding genetic risk factors for common side effects of antidepressant medications","volume":"1","author":"Campos","year":"2021","journal-title":"Commun Med (Lond)"},{"key":"2024121109571538000_nuad171-B8","first-page":"123","article-title":"Comparing clinical guidelines for the management of major depressive disorder","volume":"107","author":"Buelt","year":"2023","journal-title":"Am Fam Physician"},{"key":"2024121109571538000_nuad171-B9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut\u2013brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci"},{"key":"2024121109571538000_nuad171-B10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jfda.2019.01.002","article-title":"Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders","volume":"27","author":"Cheng","year":"2019","journal-title":"J Food Drug Anal"},{"key":"2024121109571538000_nuad171-B11","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3389\/fnins.2019.01361","article-title":"Antidepressive mechanisms of probiotics and their therapeutic potential","volume":"13","author":"Yong","year":"2019","journal-title":"Front Neurosci"},{"key":"2024121109571538000_nuad171-B12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota\u2013brain axis in behaviour and brain disorders","volume":"19","author":"Morais","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"2024121109571538000_nuad171-B13","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3390\/nu13051728","article-title":"Exploring the role and potential of probiotics in the field of mental health: major depressive disorder","volume":"13","author":"Johnson","year":"2021","journal-title":"Nutrients"},{"key":"2024121109571538000_nuad171-B14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neubiorev.2019.03.023","article-title":"Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials","volume":"102","author":"Liu","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"2024121109571538000_nuad171-B15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"2024121109571538000_nuad171-B16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/nutrit\/nuz080","article-title":"Probiotics and prebiotics: focus on psychiatric disorders\u2014a systematic review","volume":"78","author":"Barbosa","year":"2019","journal-title":"Nutr Rev"},{"key":"2024121109571538000_nuad171-B17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/14737175.2016.1155985","article-title":"Are antidepressants effective? A debate on their efficacy for the treatment of major depression in adults","volume":"16","author":"Bschor","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"2024121109571538000_nuad171-B18","doi-asserted-by":"crossref","first-page":"112595","DOI":"10.1016\/j.psychres.2019.112595","article-title":"Pharmacological and non-pharmacological treatments for major depressive disorder in adults: a systematic review and network meta-analysis","volume":"281","author":"Chen","year":"2019","journal-title":"Psychiatry Res"},{"key":"2024121109571538000_nuad171-B19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.medcli.2016.02.025","article-title":"The PRISMA statement extension for systematic reviews incorporating network meta-analysis: PRISMA-NMA","volume":"147","author":"Hutton","year":"2016","journal-title":"Med Clin (Barc)"},{"key":"2024121109571538000_nuad171-B20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","author":"Rouse","year":"2017","journal-title":"Intern Emerg Med"},{"key":"2024121109571538000_nuad171-B21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/jcm10040647","article-title":"Updated review and meta-analysis of probiotics for the treatment of clinical depression: adjunctive vs. stand-alone treatment","volume":"10","author":"Nikolova","year":"2021","journal-title":"J Clin Med"},{"key":"2024121109571538000_nuad171-B22","author":"VA\/DoD Clinical Practice Guideline","year":"2022"},{"key":"2024121109571538000_nuad171-B23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13643-016-0368-4","article-title":"Data extraction for complex meta-analysis (DECiMAL) guide","volume":"5","author":"Pedder","year":"2016","journal-title":"Syst Rev"},{"key":"2024121109571538000_nuad171-B24","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.4","author":"Higgins","year":"2023"},{"key":"2024121109571538000_nuad171-B25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.20982\/tqmp.14.4.p242","article-title":"A review of effect sizes and their confidence intervals, Part I: the Cohen's d family","volume":"14","author":"Goulet-Pelletier","year":"2018","journal-title":"TQMP"},{"key":"2024121109571538000_nuad171-B26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2024121109571538000_nuad171-B27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.psyneuen.2018.10.010","article-title":"Probiotic Lactobacillus plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: a double-blind, randomized, placebo controlled study","volume":"100","author":"Rudzki","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"2024121109571538000_nuad171-B28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jclinepi.2018.11.025","article-title":"GRADE approach to rate the certainty from a network meta-analysis: addressing incoherence","volume":"108","author":"Brignardello-Petersen","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"2024121109571538000_nuad171-B29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41380-022-01824-z","article-title":"Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis","volume":"28","author":"Kishi","year":"2023","journal-title":"Mol Psychiatry"},{"key":"2024121109571538000_nuad171-B30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.18549\/PharmPract.2017.01.943","article-title":"Network meta-analysis: a technique to gather evidence from direct and indirect comparisons","volume":"15","author":"Tonin","year":"2017","journal-title":"Pharm Pract (Granada)"},{"key":"2024121109571538000_nuad171-B31","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3102\/1076998616664876","article-title":"Just Another Gibbs Sampler (JAGS) flexible software for MCMC implementation","volume":"41","author":"Depaoli","year":"2016","journal-title":"J Educ Behav Stat"},{"key":"2024121109571538000_nuad171-B32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nut.2015.09.003","article-title":"Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Akkasheh","year":"2016","journal-title":"Nutrition"},{"key":"2024121109571538000_nuad171-B33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.29219\/fnr.v62.1218","article-title":"Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study","volume":"62","author":"Majeed","year":"2018","journal-title":"Food Nutr Res"},{"key":"2024121109571538000_nuad171-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2020.01.102","article-title":"Gut microbiota and major depressive disorder: a systematic review and meta-analysis","volume":"266","author":"Sanada","year":"2020","journal-title":"J Affect Disord"},{"key":"2024121109571538000_nuad171-B35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10787-017-0311-x","article-title":"A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested","volume":"25","author":"Bambling","year":"2017","journal-title":"Inflammopharmacology"},{"key":"2024121109571538000_nuad171-B36","doi-asserted-by":"crossref","DOI":"10.3390\/nu14010037","article-title":"The role of the gut microbiota in the development and progression of major depressive and bipolar disorder","volume":"14","author":"Knuesel","year":"2021","journal-title":"Nutrients"},{"key":"2024121109571538000_nuad171-B37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.tins.2016.09.002","article-title":"Psychobiotics and the manipulation of bacteria-gut-brain signals","volume":"39","author":"Sarkar","year":"2016","journal-title":"Trends Neurosci"},{"key":"2024121109571538000_nuad171-B38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/HRP.0000000000000243","article-title":"Gutted! Unraveling the role of the microbiome in major depressive disorder","volume":"28","author":"Bastiaanssen","year":"2020","journal-title":"Harv Rev Psychiatry"},{"key":"2024121109571538000_nuad171-B39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fpsyt.2019.00034","article-title":"Systematic review of gut microbiota and major depression","volume":"10","author":"Cheung","year":"2019","journal-title":"Front Psychiatry"},{"key":"2024121109571538000_nuad171-B40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","article-title":"Serotonin: a review","volume":"31","author":"Mohammad-Zadeh","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"2024121109571538000_nuad171-B41","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1176\/appi.ajp.2014.14010067","article-title":"Glutamate metabolism in major depressive disorder","volume":"171","author":"Abdallah","year":"2014","journal-title":"Am J Psychiatry"},{"key":"2024121109571538000_nuad171-B42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","article-title":"Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine","volume":"81","author":"Lener","year":"2017","journal-title":"Biol Psychiatry"},{"key":"2024121109571538000_nuad171-B43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2018.07.006","article-title":"Probiotics for the treatment of depressive symptoms: an anti-inflammatory mechanism?","volume":"73","author":"Park","year":"2018","journal-title":"Brain Behav Immun"},{"key":"2024121109571538000_nuad171-B44","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"2024121109571538000_nuad171-B45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/acps.12978","article-title":"Leaky gut biomarkers in depression and suicidal behavior","volume":"139","author":"Ohlsson","year":"2019","journal-title":"Acta Psychiatr Scand"},{"key":"2024121109571538000_nuad171-B46","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"key":"2024121109571538000_nuad171-B47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jad.2016.09.012","article-title":"Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness","volume":"208","author":"Macedo","year":"2017","journal-title":"J Affect Disord"},{"key":"2024121109571538000_nuad171-B48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jad.2017.11.063","article-title":"A meta-analysis of the use of probiotics to alleviate depressive symptoms","volume":"228","author":"Ng","year":"2018","journal-title":"J Affect Disord"},{"key":"2024121109571538000_nuad171-B49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41398-022-01977-z","article-title":"Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial","volume":"12","author":"Schaub","year":"2022","journal-title":"Transl Psychiatry"},{"key":"2024121109571538000_nuad171-B50","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fmicb.2017.01162","article-title":"Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity","volume":"8","author":"Gupta","year":"2017","journal-title":"Front Microbiol"},{"key":"2024121109571538000_nuad171-B51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"2024121109571538000_nuad171-B52","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2019.01.001","article-title":"Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle","volume":"176","author":"Pasolli","year":"2019","journal-title":"Cell"}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/83\/1\/72\/61007519\/nuad171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/83\/1\/72\/61007519\/nuad171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:15:01Z","timestamp":1733894101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article\/83\/1\/72\/7536066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,14]]},"published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/nutrit\/nuad171","relation":{},"ISSN":["0029-6643","1753-4887"],"issn-type":[{"value":"0029-6643","type":"print"},{"value":"1753-4887","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,1,14]]}}}